Professor of Urology, Academic Consultant Urologist, Prostate Cancer Research. prior CRUK/RCSEng Clinician Scientist Fellow. RT not endorsement. views my own.
Oxford, England
Joined May 2018
- Tweets301
- Following256
- Followers341
- Likes945
@"PART (Partial Ablation vs whole gland Radical Treatment) trial protocol published in BJUI"linkedin.com/pulse/part-part… on @LinkedIn
Delighted to share our newly published PART trial protocol paper bjui-journals.onlinelibrary.… #focaltherapy #prostatecancer @NDSurgicalSci @SITU_Oxford @NIHRresearch @QuinteTBristol @PART_Trial @BJUIjournal We continue at pace to deliver high level evidence in the field
Extremely grateful to collaborators @marclaniado @treatyOfSharma @tomleslie21 @AltanOmerElvis @UroDocKotwal @john_withington @mrsprostate @IP_London @LondonProstate1 @TaimurShah @angiodynamics @FocalOneHIFU and funder @NIHRresearch and currently recruited, and future, patients
It is more important than ever to deliver high level evidence in this field, to fully inform patients and clinicians. #focaltherapy #prostatecancer #hifu #NanoKnife very grateful to everyone involved in delivering the @PART_Trial in the UK
Congrats to @treatyOfSharma & the @NHS_Lothian Team, who have just recruited the 200th patient to the @PART_Trial We are almost 2/3 way to our target of 306 randomised participants. 👏 @LabBryant @NDSurgicalSci @NIHRresearch @OCTRUctu @SITU_Oxford @QuinteTBristol #prostatecancer
The need for #highlevelevidence for #focaltherapy for localised #prostatecancer is greater than ever. The @PART_Trial team is grateful to all current & future recruited participants, and to the trial sites - and we continue at pace to deliver a pivotal @NIHRresearch funded trial
In further good news, our @PART_Trial protocol manuscript has just been accepted for publication, and I look forward to sharing this publication very soon. @treatyOfSharma @daisy__elliott @marclaniado @tomleslie21 @AltanOmerElvis
Bryant_Lab retweeted
👀Watch this space @PART_Trial are nearly at another milestone‼️Thanks to all involved 👏@LabBryant @NDSurgicalSci @QuinteTBristol @SITU_Oxford @OCTRUctu
Great to see so many site PIs and research nurses and team members at the @PART_Trial Investigators Meeting. Full RCT of #focaltherapy for T2 GGG2-3 #prostatecancer across the UK @SITU_Oxford @NDSurgicalSci - onwards and upwards!!
Thanks to everyone that was able to join us for our @PART_Trial Investigator's meeting on Friday 5th June and congratulations to our award winners!🏆👏😊@LabBryant @SITU_Oxford @OCTRUctu @NDSurgicalSci @OUHospitals @NHS_Lothian @FrimleyHealth
Nice interview. We are doing a full scale RCT of #focaltherapy for #prostate cancer (T2, GGG2-3) across the UK - @PART_Trial is recruiting @SITU_Oxford @treatyOfSharma @marclaniado @tomleslie21 @IP_London
🚨Focal therapy for #prostatecancer🚨
❔Who is the ideal candidate for trials to investigate?
🎙️@LondonProstate1 weighs in on this episode of the #UroOncMinute live from #EAU26
@Uroweb @IP_London @UrologyTimes
🔗shorturl.at/vpMaY
Bryant_Lab retweeted
Thanks to everyone that was able to join us for our @PART_Trial Investigator's meeting on Friday 5th June and congratulations to our award winners!🏆👏😊@LabBryant @SITU_Oxford @OCTRUctu @NDSurgicalSci @OUHospitals @NHS_Lothian @FrimleyHealth
Grateful to @BJUIjournal for publishing “The PRAGMATIC pathway ‐ PRostate cancer diAGnosis and MAnagement Triage In Clinical care”. Effective triaging steps for the highest risk suspected prostate cancer patients for rapid diagnosis & treatment bjui-journals.onlinelibrary.…
Bryant_Lab retweeted
A ground-breaking new study will test how artificial intelligence can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK.
Read more ➡️ nds.ox.ac.uk/news/new-ai-too…
ALT NDS logo, Picture of Clare Verrill using software, text that reads: New AI tool could improve prostate cancer treatment, www.nds.ox.ac.uk
🎉SARONG just hit 800 participants! A huge THANK YOU to all the incredible research teams and especially to our amazing participants. We are so grateful for your support! #ResearchMilestone #ThankYou @MarkarSheraz @SITU_Oxford @OCTRUctu @NDSurgicalSci
Tremendous news - well done @NHSBartsHealth !! Looking forward to further recruited participants in this key @NIHRresearch funded RCT of #focaltherapy versus radical treatment for #prostatecancer from @SITU_Oxford @OCTRUctu @QuinteTBristol @LabBryant
...and they're off! @NHSBartsHealth have recruited their 1st participant to the PART_Trial 🥳Congrats to all involved 👏 @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol
Tremendous!! Many congratulations @MarkarSheraz Safe trip home, and it will be exciting to learn of your new collaborations and ideas for TransAtlantic Surgical Research!!!
Brilliant @AmCollSurgeons Congress in Chicago! So grateful to receive the international guest scholarship! Wonderful catching up with old and new friends. Brilliant to build stronger links between US UK for collaborative clinical trials. @NDSurgicalSci
Bryant_Lab retweeted
The seasons may be changing but there's lots to celebrate - as #PART has just recruited it's 110th participant thanks to the @OUHospitals team 🥳@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol
Bryant_Lab retweeted
We've recently welcomed @nhsuhcw to #PART and they have already recruited their 1⃣st participant‼️Well done to all 🥳👏@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol
Thrilled to have been awarded full Professor of Urology at @NDSurgicalSci at @UniofOxford Huge thank you to all who have supported me - starting at @BryntegSixth to @sheffielduni then @UniofOxford - & especially @Freddie_Hamdy & my family & colleagues. #prostatecancer #research
A big day for the @PART_Trial 100 recruited participants, a significant way towards our required sample size, with the aim of delivering level 1 evidence for #focaltherapy versus #radicaltreatment for #prostatecancer @NIHRresearch @SITU_Oxford @QuinteTBristol @OCTRUctu
We did it!! #PART has recruited its 1⃣0⃣0⃣th participant at @FrimleyHealth 🥳 a massive thank you and to all our #PARTsites for your hard work getting us there!!!👏we are a step closer to answering our important question 👍@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol